How does Forest Labs spell relief? P-A-T-E-N-T. A federal court has validated the company's Lexapro protection, safeguarding that blockbuster antidepressant and antianxiety drug through 2012. The court also intervened to stop Teva Pharmaceuticals from launching a generic version of Lexapro [1], which is Forest's top seller at $2 billion per year.
- check out the release [2]
Related Articles:
FDA OKs generic Lexapro. Report [1]
Lundbeck chair hits exit. Report [3]
Forest Labs dumps failed stroke drug program. Report [4]
Links:
[1] http://www.fiercebiotech.com/story/spotlight-fda-oks-generic-lexapro/2006-05-23?utm_source=related&utm_medium=internal
[2] http://www.fiercebiotech.com/press-releases/press-release-forest-laboratories-announces-federal-appeals-court-upholds-lexapro-pat
[3] http://www.fiercepharma.com/story/lundbeck-chair-hits-exit/2007-08-27
[4] http://www.fiercebiotech.com/story/forest-labs-dumps-failed-stroke-drug-program/2007-08-30?utm_source=related&utm_medium=internal